Response Biomedical expands distribution of cardiovascular products in the U.S.

Vancouver's Response Biomedical Corp. (TSC: RBM) (OTCBB: RPBIF) has entered into a distribution agreement with Laboratory Supply Company, Inc. (LABSCO) in Louisville, Kentucky, to distribute ...

Vancouver's Response Biomedical Corp. (TSC: RBM) (OTCBB: RPBIF) has entered into a distribution agreement with Laboratory Supply Company, Inc. (LABSCO) in Louisville, Kentucky, to distribute cardiovascular products in the U.S. to hospitals with fewer than 150 beds.

LABSCO is the largest privately held distributor of clinical lab products in the U.S.

"This is a very important agreement for Response as it marks a significant step into the U.S. market for POCT [point-of-care testing] in the cardiovascular areana, which is one of the largest markets in the world," said Tim Shannon, Response Biomedical Corp.'s senior vice-president of worldwide sales and marketing.

"LABSCO has the experience and reputation to maximize our efforts to gain traction and to help us penetrate a market that we believe will greatly enhance our growth in the near term and beyond."

The POCT market in the U.S. is worth an estimated $3.1 billion.

ecrawford@biv.com

@EmmaCrawfordBIV

comments powered by Disqus

More from Technology

PayPal continues to expand its B.C. footprint

A $304m acquisition of a Vancouver fintech is just the latest move for the payments giant

Read Article

Hootsuite buys analytics company LiftMetrix

Read Article

‘Virtual realty’ delivers B.C. property to foreign buyers

Realtors, developers tap VR to plug offshore buyers into local real estate from abroad

Read Article

BIV on Global BC February 17, 2017: Blackberry class action lawsuit. Plus: ...

Hayley Woodin discusses a class action lawsuit launched against Blackberry. Plus: Airbnb beats Expedia to luxury brand deal

Read Article

Subscribe to our mailing lists

* indicates required

Newsletters

* You can modify your newsletter subscriptions at the bottom of any newsletter you receive.
×